Inogen Inc
NASDAQ:INGN

Watchlist Manager
Inogen Inc Logo
Inogen Inc
NASDAQ:INGN
Watchlist
Price: 8.565 USD 1.6%
Market Cap: 204m USD
Have any thoughts about
Inogen Inc?
Write Note

Inogen Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inogen Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Inogen Inc
NASDAQ:INGN
Cash & Cash Equivalents
$105.7m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Cash & Cash Equivalents
$1.7B
CAGR 3-Years
-9%
CAGR 5-Years
26%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Cash & Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash & Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash & Cash Equivalents
$7.6B
CAGR 3-Years
-7%
CAGR 5-Years
13%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash & Cash Equivalents
$2.4B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
17%
No Stocks Found

Inogen Inc
Glance View

Market Cap
204m USD
Industry
Health Care

Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 1,021 full-time employees. The company went IPO on 2014-02-14. The firm primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen with a single battery and can be plugged into a power outlet as needed. All of its Inogen One systems are equipped with Intelligent Delivery Technology, a form of pulse-dose technology, from which the patient receives a bolus of oxygen upon inhalation. The company has also launched Inogen Connect, a wireless connectivity platform for the Inogen One G4 and Inogen One G5 (portable oxygen concentrators) consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.

INGN Intrinsic Value
13.603 USD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Inogen Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
105.7m USD

Based on the financial report for Sep 30, 2024, Inogen Inc's Cash & Cash Equivalents amounts to 105.7m USD.

What is Inogen Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
7%

Over the last year, the Cash & Cash Equivalents growth was -15%. The average annual Cash & Cash Equivalents growth rates for Inogen Inc have been -24% over the past three years , -8% over the past five years , and 7% over the past ten years .

Back to Top